| 000 | 01673cam a2200277 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031024.0 | ||
| 008 | 140812s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2012.Ah.N | ||
| 100 | 0 | _aAhmed Shafiek Attia | |
| 245 | 1 | 0 |
_aNovel nebulized nanoemulsion for pulmonary delivery of sildenafil citrate : _bPreclinical and clinical studies / _cAhmed Shafiek Attia ; Supervised Hanan Ellaithy |
| 246 | 1 | 5 |
_aمستحلبات دقيقة جديدة ذات جزيئات نانونية للتوصل الرئوى لعقار السيلدينافيل سيتريت عن طريق الرذاذة : _bدراسة معملية و إكلينيكية |
| 260 |
_aCairo : _bAhmed Shafiek Attia , _c2012 |
||
| 300 |
_a97 Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Technology | ||
| 520 | _aSildenafil citrate (SC) is the first orally active drug approved by the FDA for the treatment of male erectile dysfunction and pulmonary hypertension. The aim of the present work was to formulate sildenafit citrate in a nanoemulsion (NE) system for administration by inhatation rouye to attain rapid onset of action with good efficacy at lower dose. Sildenafit citrate saturated solubility was determined in different oils, surfactants, co - surfactants | ||
| 700 | 0 |
_aHanan Ellaithy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c46839 _d46839 |
||